Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01886326 · ClinicalTrials.gov registry record · NA

Eating Peanuts for Health

A NA study of Obesity and Overweight, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
196
Enrollment target
1
Study location

NCT01886326: Completed NA study of Obesity and Overweight, sponsored by Purdue University.

NCT01886326 is a NA study of Obesity and Overweight that has completed, run by Purdue University. The registered enrollment target is 196 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01886326, a NA study of Obesity and Overweight, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
196 participants
Enrollment target
1
Study location

Study Summary

Evidence is accumulating that peanut consumption confers health benefits, such as reduction of cardiovascular disease risk and possibly diabetes risk (Jenkins et al., 2008; Mattes et al., 2008). However, peanuts are a high fat, energy dense food and concerns about weight gain are widespread. Although research indicates that other characteristics of peanuts offset these properties, and that peanuts may be incorporated into diets without posing a threat to weight gain (Mattes et al., 2008), concern remains among policymakers, healthcare providers, and consumers. Furthermore, worry exists that eating salted peanuts may elevate blood pressure and that eating honey-roasted peanuts make elevate blood sugar. These fears create substantial obstacles to increased peanut consumption. Recommendations to increase peanut consumption may be made, but if they are not followed, there will be no impact on health. Additional knowledge is needed on: (1) the acceptability of peanuts consumed on a chronic basis, (2) the chronic intake of moderate levels of peanuts and body weight, and 3) the effects of peanuts on blood pressure and blood sugar. The proposed research will examine the acceptability of long-term inclusion of a single form versus varied forms of peanuts in the diet. It is expected that responses will be varied among individuals with different personality characteristics (e.g., prefer sweet versus savory foods, hedonic versus non-hedonic eaters). A better understanding of how different segments of the population choose to include peanuts in their diet and how to optimize long-term consumption should provide insights for better marketing and improved health. Furthermore, it is anticipated that eating salty peanuts will not raise blood pressure and that eating honey-roasted peanuts will not raise blood sugar. Documenting this will add credibility to the evidence that peanuts do not cause weight gain, as well as reinforce recommendations to increase peanut consumption for thei

Interventions

  • OTHER Consumption of 42 grams of peanuts daily

Study Locations (1)

Indiana

  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2010-02
Est. Completion 2012-05
Phase NA
Purdue University

141 total trials

What the finished NCT01886326 record still lists

NCT01886326 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Consumption of 42 grams of peanuts daily is the first listed.

NCT01886326 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT01886326 about?

NCT01886326 is a clinical study titled "Eating Peanuts for Health". Evidence is accumulating that peanut consumption confers health benefits, such as reduction of cardiovascular disease risk and possibly diabetes risk (Jenkins et al., 2008; Mattes et al., 2008). However, peanuts are a high fat, energy dense food and concerns about weight gain are widespread. Althoug...

What is the current status of trial NCT01886326?

This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2010-02. Estimated completion is 2012-05.

What conditions does trial NCT01886326 study?

This clinical trial studies the following conditions: Obesity, Overweight, Hyperlipidemia.

What interventions are being tested in trial NCT01886326?

The interventions under investigation include: Consumption of 42 grams of peanuts daily (OTHER).

Who is sponsoring clinical trial NCT01886326?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01886326 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01886326's enrollment target sits among peer trials

196 326th of 1053 higher than 728 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02822768 · 196 participants · NA

    Packing Versus no Packing for Cutaneous Abscess

  • NCT04250259 · 196 participants · Phase 2

    SAMe Trial for Patients With Alcoholic Cirrhosis

  • NCT05142592 · 196 participants · Phase 1

    Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

  • NCT05317832 · 196 participants · Phase 2

    Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01886326, the US trial registry maintained by the National Library of Medicine. NCT01886326 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.